Product Description
a sterile depot suspension with DPT native extract (Sourced from: http://www.alergialafe.org/descargas/revistas/IT%20ACAROS-FASE%20I%20-%20BIAL.pdf)
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Peptide/Protein
Route of Administration: Subcutaneous
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Greece
Approved Indications: None
Company: Bial
Company Location: Europe
Company Founding Year: 1924
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Conjunctivitis, Allergic|Conjunctivitis|Lyme Disease|Asthma, Allergic
Phase 1: Environmental Hypersensitivity|Conjunctivitis|Asthma|Grass Pollen Hypersensitivity|Conjunctivitis, Allergic
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT04112797 |
HIPNOS | N/A |
Unknown status |
Environmental Hypersensitivity |
2023-11-01 |
2025-08-27 |
Primary Endpoints|Treatments |
|
NCT03821077 |
ARES | N/A |
Completed |
Rhinitis, Allergic|Conjunctivitis, Allergic |
2021-09-13 |
2025-08-27 |
Primary Endpoints |
|
NCT02844842 |
APOLO | N/A |
Completed |
Rhinitis, Allergic|Conjunctivitis, Allergic|Asthma, Allergic |
2018-09-06 |
2019-03-20 |
Patient Enrollment|Primary Completion Date|Study Completion Date|Treatments|Trial Status |
|
NCT02881879 |
BIA-HDMD-101 | P1 |
Completed |
Conjunctivitis, Allergic |
2017-09-01 |
2019-03-20 |
Treatments |
|
NCT02849210 |
BIA-OLEA-DEPOT | P1 |
Completed |
Conjunctivitis |
2017-06-02 |
2019-03-20 |
Treatments |
|
NCT02849249 |
BIA-OLEAPHL-POLI-100 | P1 |
Completed |
Environmental Hypersensitivity|Conjunctivitis|Asthma|Grass Pollen Hypersensitivity |
2016-06-01 |
2019-03-20 |
Treatments |
|
NCT02477917 |
BIA-PAR-DEPOT | P1 |
Completed |
Conjunctivitis |
2016-03-01 |
2019-03-20 |
Treatments |
|
2016-002944-18 |
2016-002944-18 | P2 |
Terminated |
Lyme Disease|Asthma, Allergic|Conjunctivitis, Allergic |
2017-04-10 |
2022-03-13 |
Treatments |
|
2014-001459-22 |
BIA-PAR-DEPOT | P2 |
Completed |
Conjunctivitis |
2016-03-11 |
2022-03-13 |
Treatments |
|
NCT01564017 |
BIA--DPT-P2-001 | P2 |
Completed |
Conjunctivitis, Allergic |
2013-05-01 |
2019-03-19 |
Treatments |
|
2011-000814-21 |
2011-000814-21 | P2 |
Completed |
Conjunctivitis, Allergic |
2013-04-22 |
2022-03-13 |
Treatments |
|
NCT01567306 |
BIA-PHL-P2-001 | P2 |
Completed |
Conjunctivitis, Allergic |
2013-04-01 |
2019-03-19 |
Treatments |
|
2004-004317-42 |
2004-004317-42 | P4 |
Active, not recruiting |
Unknown |
2007-06-24 |
2022-03-12 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|